Punnee Pitisuttithum

Summary

Affiliation: Center for Infectious Disease and Vaccine Research
Country: Thailand

Publications

  1. ncbi Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand
    Punnee Pitisuttithum
    Department of Clinical Tropical Medicine, Mahidol University, Bangkok 10400, Thailand
    J Infect Dis 194:1661-71. 2006
  2. ncbi Efficacy and safety of generic fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-vir) in advanced HIV infection
    Aneley Getahun
    Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
    J Med Assoc Thai 89:1472-8. 2006
  3. ncbi Factors associated with incarceration and incident human immunodeficiency virus (HIV) infection among injection drug users participating in an HIV vaccine trial in Bangkok, Thailand, 1999-2003
    Pravan Suntharasamai
    Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
    Addiction 104:235-42. 2009
  4. ncbi Safety and efficacy of CKBM-A01, a Chinese herbal medicine, among asymptomatic HIV patients
    Wirach Maek-A-Nantawat
    Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
    Southeast Asian J Trop Med Public Health 40:494-501. 2009
  5. ncbi 6-month evaluation of JinHuang Chinese herbal medicine study in asymptomatic HIV infected Thais
    Wirach Maek-A-Nantawat
    Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
    Southeast Asian J Trop Med Public Health 34:379-84. 2003
  6. ncbi Phase I/II study of a candidate vaccine designed against the B and E subtypes of HIV-1
    Punnee Pitisuttithum
    Vaccine Trial Center, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
    J Acquir Immune Defic Syndr 37:1160-5. 2004
  7. ncbi Effectiveness of fixed-dose combination stavudine, lamivudine and nevirapine (GPO-VIR) for treatment of naïve HIV patients in Thailand: a 3-year follow-up
    Varunee Desakorn
    Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
    Southeast Asian J Trop Med Public Health 42:1414-22. 2011
  8. ncbi Social harms in injecting drug users participating in the first phase III HIV vaccine trial in Thailand
    Punnee Pitisuttithum
    Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
    J Med Assoc Thai 90:2442-8. 2007
  9. ncbi Immune reconstitution inflammatory syndrome in adult human immunodeficiency virus-infected patients in Thailand
    Maie Aramaki
    Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok Thailand
    Southeast Asian J Trop Med Public Health 41:138-45. 2010
  10. ncbi Safety and immunogenicity of combinations of recombinant subtype E and B human immunodeficiency virus type 1 envelope glycoprotein 120 vaccines in healthy Thai adults
    Punnee Pitisuttithum
    Vaccine Trial Centre, Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Siriraj Hospital, Mahidol University, 420 6 Rajvithi Road, Bangkok 10400, Thailand
    J Infect Dis 188:219-27. 2003

Collaborators

Detail Information

Publications35

  1. ncbi Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand
    Punnee Pitisuttithum
    Department of Clinical Tropical Medicine, Mahidol University, Bangkok 10400, Thailand
    J Infect Dis 194:1661-71. 2006
    ....
  2. ncbi Efficacy and safety of generic fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-vir) in advanced HIV infection
    Aneley Getahun
    Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
    J Med Assoc Thai 89:1472-8. 2006
    ..9%, 14.7% and 6.9%, respectively. CONCLUSION: GPO-vir was well tolerated and effective in increasing CD4 cell count and suppressing plasma viremia in advanced HIV infection during the 48 weeks follow-up period...
  3. ncbi Factors associated with incarceration and incident human immunodeficiency virus (HIV) infection among injection drug users participating in an HIV vaccine trial in Bangkok, Thailand, 1999-2003
    Pravan Suntharasamai
    Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
    Addiction 104:235-42. 2009
    ..To determine if incarceration was associated with human immunodeficiency virus (HIV) infection and identify risk factors for incarceration among injection drug users (IDUs) participating in an HIV vaccine trial in Bangkok...
  4. ncbi Safety and efficacy of CKBM-A01, a Chinese herbal medicine, among asymptomatic HIV patients
    Wirach Maek-A-Nantawat
    Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
    Southeast Asian J Trop Med Public Health 40:494-501. 2009
    ..019). CKBM-A01 appeared to be safe but gave no significant improvement in QoL in asymptomatic HIV patients, and gave no significant improvement in the treatment of HIV based on CD4 cell counts and viral loads...
  5. ncbi 6-month evaluation of JinHuang Chinese herbal medicine study in asymptomatic HIV infected Thais
    Wirach Maek-A-Nantawat
    Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
    Southeast Asian J Trop Med Public Health 34:379-84. 2003
    ..Most of the patients felt that the quality of life was better in terms of better appetite, good sleep and healthy during study participation, however, these were subjective...
  6. ncbi Phase I/II study of a candidate vaccine designed against the B and E subtypes of HIV-1
    Punnee Pitisuttithum
    Vaccine Trial Center, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
    J Acquir Immune Defic Syndr 37:1160-5. 2004
    ..Using the B/E combination did not interfere with the response to either clade. Antibodies to AIDSVAX B/E were able to bind to oligomeric gp120 on the surface of cells infected with primary isolates of HIV-1...
  7. ncbi Effectiveness of fixed-dose combination stavudine, lamivudine and nevirapine (GPO-VIR) for treatment of naïve HIV patients in Thailand: a 3-year follow-up
    Varunee Desakorn
    Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
    Southeast Asian J Trop Med Public Health 42:1414-22. 2011
    ..3%). Thirty-six patients (27%) switched from GPO-VIR to other anti-retroviral drugs regimens due to lipodystrophy. This study showed GPO-VIR had clinical and immunological benefits, but one-third of patients had adverse effects...
  8. ncbi Social harms in injecting drug users participating in the first phase III HIV vaccine trial in Thailand
    Punnee Pitisuttithum
    Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
    J Med Assoc Thai 90:2442-8. 2007
    ..To study related social harms due to identification with a group of participants in an HIV-1 vaccine trial who are potentially high risk for HIV/AIDS...
  9. ncbi Immune reconstitution inflammatory syndrome in adult human immunodeficiency virus-infected patients in Thailand
    Maie Aramaki
    Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok Thailand
    Southeast Asian J Trop Med Public Health 41:138-45. 2010
    ..001). The incidence of IRIS in advanced adult HIV-infected patients in Thailand was lower than that reported from Europe and the United States, which may be attributable to deferment of HAART after diagnosing opportunistic infections...
  10. ncbi Safety and immunogenicity of combinations of recombinant subtype E and B human immunodeficiency virus type 1 envelope glycoprotein 120 vaccines in healthy Thai adults
    Punnee Pitisuttithum
    Vaccine Trial Centre, Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Siriraj Hospital, Mahidol University, 420 6 Rajvithi Road, Bangkok 10400, Thailand
    J Infect Dis 188:219-27. 2003
    ..There was no evidence of antigenic interference in HIV-specific humoral or cellular responses. The gp120 Thai E and SF2 vaccines were safe and immunogenic in combination and could be advanced into phase 3 testing...
  11. ncbi HIV vaccine research in Thailand: lessons learned
    Punnee Pitisuttithum
    Faculty of Tropical Medicine, Mahidol University, 40 6 Ratchavithi Road, Ratchathewi, Bangkok 10400, Thailand
    Expert Rev Vaccines 7:311-7. 2008
    ..However, many lessons learned can be utilized or modified for other vaccine trials, particularly vaccines against other infectious diseases prevalent in developing countries...
  12. ncbi Psychosocial burden of women with abnormal Pap smears
    Benjaluck Phonrat
    Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
    Southeast Asian J Trop Med Public Health 40:593-601. 2009
    ....
  13. ncbi Safety and reactogenicity of canarypox ALVAC-HIV (vCP1521) and HIV-1 gp120 AIDSVAX B/E vaccination in an efficacy trial in Thailand
    Punnee Pitisuttithum
    Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
    PLoS ONE 6:e27837. 2011
    ..2% for prevention of HIV acquisition in HIV-uninfected adults participating in a community-based efficacy trial in Thailand...
  14. ncbi HIV-1 prophylactic vaccine trials in Thailand
    Punnee Pitisuttithum
    Clinical Infectious Diseases Research Unit, Faculty of Tropical Medicine, Mahidol University, 420 6 Ratchawithi Road, Bangkok 10400, Thailand
    Curr HIV Res 3:17-30. 2005
    ..With committed parties in medical science, government, industry and the community, we hope that we can achieve success in developing a safe and effective HIV vaccine in the near future...
  15. ncbi HIV-vaccine research and development in Thailand: evolution and challenges
    Punnee Pitisuttithum
    Faculty of Tropical Medicine, Mahidol University 420 6 Ratchawithi Road, Ratchathewi, Bangkok 10400, Thailand
    Vaccine 28:B45-9. 2010
    ..However, there were different issues in recruitment process, follow up, social impact events and community involvement since the target participants were different...
  16. ncbi Knowledge, attitudes, and acceptability of a human papillomavirus vaccine among healthcare providers
    Archin Songthap
    Department of Tropical Hygiene, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
    Southeast Asian J Trop Med Public Health 40:1048-56. 2009
    ..Almost all the nurses and doctors suggested that adolescent aged < or = 18-years-old should be the target group for HPV vaccination. Furthermore, 73% of nurses and 76% of doctors would recommend clients to receive HPV vaccine...
  17. ncbi The efficacy and adverse effects of GPO-VIR (stavudine+lamivudine+nevirapine) in treatment-naïve adult HIV patients
    Ei Ei Tin
    Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
    Southeast Asian J Trop Med Public Health 36:362-9. 2005
    ..043). GPO-VIR is an inexpensive and effective antiretroviral drug regimen for initiating treatment of naïve patients, but careful assessment for lipodystrophy is necessary, especially after one year of treatment...
  18. ncbi Evaluation of attitude, risk behavior and expectations among Thai participants in Phase I/II HIV/AIDS vaccine trials
    Wirach Maek-A-Nantawat
    Vaccine Trial Center, Faculty of Tropical Medicine, Mahidol University, Bangkok 10700, Thailand
    J Med Assoc Thai 86:299-307. 2003
    ..0001). All of the volunteers expressed the beneficial expectations as knowledge gain, social contribution, feelings of having gained merit and self-benefits from health check-ups...
  19. ncbi Pregnancy Outcomes Among HIV-Infected Women Undergoing Antiretroviral Therapy
    Darin Areechokchai
    Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
    Open AIDS J 3:8-13. 2009
    ..004). CONCLUSION: Adverse ARV events were more numerous among the pregnant women who needed ART than PMTCT. ANC is beneficial and strongly recommended for all pregnant HIV-infected women for better pregnancy outcomes...
  20. ncbi Clinical features, aetiology and short-term outcome of interstitial pneumonitis in HIV/AIDS patients at Bamrasnaradura Hospital, Nonthaburi, Thailand
    Ariane Knauer
    Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
    Wien Klin Wochenschr 117:49-55. 2005
    ..6% had clinically improved. The cumulative survival after 28 days was highest among PCP patients, followed by bacterial pneumonia, TB and fungal pneumonia, but these differences were statistically not significant (p = 0.453)...
  21. ncbi Estimation of the total parasite biomass in acute falciparum malaria from plasma PfHRP2
    Arjen M Dondorp
    Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
    PLoS Med 2:e204. 2005
    ..CONCLUSION: Plasma PfHRP2 concentrations may be used to estimate the total body parasite biomass in acute falciparum malaria. Severe malaria results from extensive sequestration of parasitised erythrocytes...
  22. ncbi Mycobacterium tuberculosis infection among HIV/AIDS patients in Thailand: clinical manifestations and outcomes
    Nimfa M Putong
    Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
    Southeast Asian J Trop Med Public Health 33:346-51. 2002
    ..Among those who survived, only 11.4% had been successfully treated; the rest had not improved due to relapse (2.9%), therapeutic failure (8.8%), treatment in progress (5.9%), and failure to complete treatment (10.7%)...
  23. ncbi A randomized, double-blind, placebo-controlled trial of acetazolamide for the treatment of elevated intracranial pressure in cryptococcal meningitis
    Paul N Newton
    Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
    Clin Infect Dis 35:769-72. 2002
    ....
  24. ncbi Clinical and mycological responses to fluconazole and fluconazole MIC in oropharyngeal candidiasis in HIV-infected patients
    Valai Bussaratid
    Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
    J Med Assoc Thai 85:757-64. 2002
    ..albicans, C. glabrata, and C. krusei ranged from 0.125-32 (median=0.250), 4-64 (median=2), and 8 g/L respectively. This study showed that the MICs to fluconazole of oropharyngeal Candida was a good predictor of the therapeutic responses...
  25. ncbi Recruiting volunteers for a multisite phase I/II HIV preventive vaccine trial in Thailand
    Darawan Thapinta
    Faculty of Nursing and Research Institute of Health Sciences, Chiang Mai University, Chiang Mai, Thailand
    J Acquir Immune Defic Syndr 30:503-13. 2002
    ..The frequent presence of mixed (altruistic and nonaltruistic) motives at initial contact suggests that motivation for trials is more complex than has been previously acknowledged...
  26. ncbi Specific antibody responses to vaccination with bivalent CM235/SF2 gp120: detection of homologous and heterologous neutralizing antibody to subtype E (CRF01.AE) HIV type 1
    Jerome H Kim
    U S Military HIV Research Program, Rockville, Maryland 20850, USA
    AIDS Res Hum Retroviruses 19:807-16. 2003
    ..Whether the NAb detected by the CM235M4-C4.6/A3R5 system is qualitatively different from those in more traditional NP03/H9 assays will require further study...
  27. ncbi Lack of increased HIV risk behavior among injection drug users participating in the AIDSVAX B/E HIV vaccine trial in Bangkok, Thailand
    Frits van Griensvan
    Thailand Ministry of Public Health-US Centers for Disease Control and Prevention Collaboration, Nonthaburi
    AIDS 18:295-301. 2004
    ..CONCLUSIONS: Injection drug use and needle sharing decreased during the first 12 months of the trial. No increases in risk behavior in relation to beliefs about vaccine protection against HIV infection could be identified...
  28. ncbi Recruitment, screening and characteristics of injection drug users participating in the AIDSVAX B/E HIV vaccine trial, Bangkok, Thailand
    Suphak Vanichseni
    Thailand Ministry of Public Health US Centers for Disease Control and Prevention Collaboration, Nonthaburi
    AIDS 18:311-6. 2004
    ....
  29. ncbi Safety and immunogenicity of an HIV subtype B and E prime-boost vaccine combination in HIV-negative Thai adults
    Sorachai Nitayaphan
    Royal Thai Component, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
    J Infect Dis 190:702-6. 2004
    ..This vaccine combination was well tolerated and was immunogenic, meeting milestones for advancement to phase 3 evaluation...
  30. ncbi Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I/II ALVAC-HIV/AIDSVAX B/E prime-boost HIV-1 vaccine trial in Thailand
    Chitraporn Karnasuta
    Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
    Vaccine 23:2522-9. 2005
    ..The results demonstrate that this HIV vaccine is a potent inducer of ADCC activity and may be an additional protection of this prime-boost vaccine in preventing HIV disease...
  31. ncbi Behavioral and social issues among volunteers in a preventive HIV vaccine trial in Thailand
    Richard A Jenkins
    Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Acquir Immune Defic Syndr 40:592-9. 2005
    ..Findings add to the evidence that preventive HIV vaccine trials are feasible in Thailand...
  32. ncbi Cross-reactivity of anti-HIV-1 T cell immune responses among the major HIV-1 clades in HIV-1-positive individuals from 4 continents
    Paul M Coplan
    Merck Research Laboratories, West Point, Pennsylvania, USA
    J Infect Dis 191:1427-34. 2005
    ..Therefore, we quantified the cross-clade reactivity, among unvaccinated individuals, of anti-HIV-1 T cell responses to the infecting HIV-1 clade relative to other major circulating clades...
  33. ncbi Clinical features, etiology and short term outcomes of interstitial pneumonitis in HIV/AIDS patients
    Somsit Tansuphasawadikul
    Bamrasnaradura Hospital, Ministry of Public Health, Nonthaburi, Thailand
    Southeast Asian J Trop Med Public Health 36:1469-78. 2005
    ..The cumulative survival after 28 days was highest among PCP patients, followed by bacterial pneumonia, tuberculosis and fungal pneumonia, but this difference was not statistically significant (p = 0.0453)...
  34. ncbi Comparison of one week with two week regimens of amphotericin B both followed by fluconazole in the treatment of cryptococcal meningitis among AIDS patients
    Somsit Tansuphaswadikul
    Bamrasnaradura Infectious Disease Institute, Department of Disease Control, Nonthaburi
    J Med Assoc Thai 89:1677-85. 2006
    ..It can be an alternative regimen to lower hospital based care and improve cost effective for source limiting health care centers...
  35. ncbi Predisposing factors for nevirapine toxicity among AIDS patients with low baseline CD4 count
    Somsit Tansuphaswadikul
    Bamrasnaradura Institute, Ministry of Public Health, Nonthaburi, Thailand
    Asian Pac J Allergy Immunol 25:147-54. 2007
    ....